MBA, Business Administration
University of Michigan, Ann Arbor, MI
PhD, Computational Biology
Rensselaer Polytechnic Institute, Troy, NY
BS, Biotechnology
Montana State University, Bozeman, MT
Patrick Buck, PhD, is an Associate Director in the Market Access and Outcomes Strategy group with RTI-HS. He has more than 10 years of biopharmaceutical experience working across all phases of asset development from early stage to launch. His skill set includes data modeling and analysis; developing payer value propositions; managing projects; conducting interviews and workshops; and preparing reports, slide sets, and other deliverables. Dr. Buck has expertise in a variety of therapeutic areas and modalities including oncology, immunology, neurology, cardiology, urology, pulmonology, rare diseases, vaccines, and medical devices. In his role at RTI-HS, Dr. Buck is involved in primary and secondary research to develop evidence-based dossiers, payer value communication toolkits, and systematic and targeted literature reviews.